Showing results (21-30 of 162) with videos related to
Sort By:
Pageof 17
Molecular Immunology|April 1, 1993
Alternatively spliced T cell receptor transcripts expressed in human T lymphocytesS Roman-Roman, L Ferradini, O Azogui, et al.Cancer Research|August 1, 1993
Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanomaA Mackensen, L Ferradini, G Carcelain, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2B Escudier, F Farace, E Angevin, et al.Cancer Research|January 15, 1996
T-cell receptor repertoire in neuroblastoma patientsD Valteau, V Scott, G Carcelain, et al.The Journal of Experimental Medicine|October 1, 1990
T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytesF Mami-Chouaib, C Miossec, P Del Porto, et al.Journal of Biological Response Modifiers|December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinomaT Hercend, F Farace, D Baume, et al.European Journal of Immunology|September 1, 1989
cDNA cloning of functional T cell receptor gamma/delta chains expressed in human peripheral blood lymphocytesF Mami-Chouaib, S Jitsukawa, F Faure, et al.Molecular Immunology|September 1, 1993
The use of anchored polymerase chain reaction for the study of large numbers of human T-cell receptor transcriptsL Ferradini, S Roman-Roman, O Azogui, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapyE Savelieva, F Farace, E Angevin, et al.The Journal of Experimental Medicine|May 1, 1990
LAG-3, a novel lymphocyte activation gene closely related to CD4F Triebel, S Jitsukawa, E Baixeras, et al.Pageof 17